Danish biosolutions company making industrial enzymes and microbial cultures for food, agriculture and household products.
Danish biosolutions company making industrial enzymes and microbial cultures for food, agriculture and household products.
Sells enzymes and microbial cultures that customers build into their own recipes and processes, such as detergent formulas and brewing, so products are specified in and rarely switched. Novo Holdings, owned by the Novo Nordisk Foundation, is the controlling shareholder. In 2025 it bought its partner's half of an animal-feed enzyme venture.
In one line: A biology-based DuPont/Ecolab hybrid.
Moat: wide (IP / patents, process know-how, scale). Leading global enzyme/microbial technology platform from the Novozymes-Chr. Hansen merger.
Headquarters: Kongens Lyngby, Denmark · Founded: 2024 · Employees: 11,641
Size Novonesis A/S (NSIS-B.CO) is a Denmark Materials company (Chemicals: Specialty) with a market value of $30.9B, the 5th largest of 60 Denmark companies the cockpit tracks. Shares closed at DKK 451.00 on 18 Nov 2026.
Performance Over six months the shares gained 16.3%, against -17.2% for the median peer and +6.3% for the Denmark market (cap-weighted) — 6th highest of 21 in its peer set.
Growth Revenue grew 5.7% over the last twelve months (peer median +6.5%); the operating margin is 22.5% (peer median 14.9%).
Valuation It trades at 30.2× forward earnings against a peer median of 17.3× (3rd most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +17%, so the hurdle is -5 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 0.1 points above its cost of capital (5.4% WACC).
Credit Novonesis A/S has 3 bonds outstanding ($1.89B), rated A- by the agencies and trading like A at a weighted spread of 93 bp.
Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | DKK 32.7B | DKK 31.0B | DKK 28.6B | DKK 17.9B | DKK 17.6B |
| Revenue growth | — | +9% | +60% | +2% | — |
| Gross profit | DKK 18.4B | DKK 14.8B | DKK 12.1B | DKK 9.31B | DKK 9.00B |
| EBITDA | DKK 12.1B | DKK 10.9B | DKK 8.80B | DKK 5.86B | DKK 5.81B |
| Net income | DKK 5.09B | DKK 4.36B | DKK 2.28B | DKK 3.02B | DKK 3.68B |
| Free cash flow | DKK 5.50B | DKK 6.06B | DKK 5.08B | DKK 2.29B | DKK 1.25B |
| Capital expenditure | DKK 4.27B | DKK 3.51B | DKK 2.68B | DKK 2.06B | DKK 2.89B |
| Total debt | DKK 23.4B | DKK 22.4B | DKK 13.4B | DKK 7.78B | DKK 6.95B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Novonesis A/S NSIS-B.CO | $30.9B | +16% | +6% | 23% | 30.2× | 12.1% |
| DSM-Firmenich DSFIR.AS | $27.5B | +47% | -45% | 8% | 28.6× | 23.7% |
| International Flavors & Fragrances IFF | $20.1B | +8% | -17% | 11% | 22.7× | 17.9% |
| Basf BAS.DE | $50.1B | 0% | -4% | 7% | 15.8× | 5.7% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | NSIS-B.CO | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -2.6% | -7.2% | 7th highest of 21 |
| 6-month return | +16.3% | -17.2% | 6th highest of 21 |
| Distance from 52-week high | -7.0% | -29.2% | 4th highest of 21 |
| Revenue growth (TTM) | +5.7% | +6.5% | 11th highest of 21 |
| Operating margin | 22.5% | 14.9% | 7th highest of 21 |
| Forward P/E | 30.2× | 17.3× | 3rd most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 12.1% | 7.9% | 6th most demanding of 18 |
| Growth delivered (Del g) | +17.2% | +6.7% | 4th highest of 18 |
| Hurdle (Req g minus delivered) | -5.1 pp | +0.9 pp | 6th least demanding of 18 |
| ROIC minus cost of capital | +0.1 pp | +0.5 pp | 11th highest of 21 |
| EV / EBITDA | 19.0× | 9.5× | 4th most expensive of 15 |
| Net debt / EBITDA | 1.6× | 1.9× | 7th least indebted of 16 |
| Bond spread | 93 bp | 81 bp | 4th widest of 8 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Novonesis A/S NSIS-B.CO | Denmark | $30.9B | +16% | +6% | 23% | 30.2× | 12.1% | +17.2% |
| Ems-chemie EMSN.SW | Switzerland | $23.1B | +21% | -3% | 30% | 38.6× | 8.2% | +1.6% |
| Ningxia Baofeng Energy 600989.SS | China | $22.2B | -27% | +35% | 35% | 7.9× | -8.3% | +24.8% |
| Dow DOW | United States | $22.0B | -15% | +4% | 5% | 14.3× | 4.4% | +0.7% |
| Basf BAS.DE | Germany | $50.1B | 0% | -4% | 7% | 15.8× | 5.7% | +0.2% |
| LyondellBasell LYB | United States | $18.9B | -18% | -2% | 10% | 9.2× | -10.3% | +1.7% |
| China Northern Rare Earth (Group) High-Tech 600111.SS | China | $17.2B | -41% | +29% | 11% | 25.0× | 22.2% | +14.2% |
| Hengli Petrochemical 600346.SS | China | $16.7B | -24% | -8% | 8% | 8.8× | -8.4% | +5.1% |
| Nippon Sanso 4091.T | Japan | $15.7B | -3% | +10% | 15% | 17.5× | 8.9% | +10.7% |
| Sociedad Quimica y Minera de Chile S.A. Sponsored ADR Pfd Series B SQM | United States | $14.6B | -40% | +59% | 39% | 6.5× | -5.9% | +20.1% |
| Symrise SY1.DE | Germany | $14.2B | +21% | -1% | 12% | 24.8× | 7.9% | +7.0% |
| Shin-etsu Chemical 4063.T | Japan | $67.9B | -22% | +5% | 25% | 17.7× | 9.9% | +11.4% |
| Air Products APD | United States | $68.6B | +7% | +8% | 24% | 21.4× | 18.7% | +4.7% |
| Resonac 4004.T | Japan | $13.8B | -29% | -9% | 15% | 21.8× | 20.0% | +6.7% |
| Satellite Chemical 002648.SZ | China | $11.9B | -16% | +20% | 23% | 6.9× | -13.6% | +33.8% |
| Zhejiang Juhua 600160.SS | China | $11.8B | -18% | -5% | 20% | 16.8× | n/a | n/a |
| Formosa Plastics 1301.TW | Taiwan | $11.8B | +41% | -5% | -3% | 17.3× | n/a | n/a |
| Lgchem 051910.KS | South Korea | $11.5B | -47% | +13% | 1% | n/a | n/a | n/a |
| Ecolab ECL | United States | $84.3B | +21% | +9% | 18% | 33.6× | 20.3% | +6.4% |
| Formosa Chemicals & Fibre 1326.TW | Taiwan | $11.3B | +53% | +9% | 1% | 22.9× | 18.2% | +2.5% |
| Albemarle ALB | United States | $10.1B | -49% | +24% | 17% | 10.3× | 5.6% | +10.4% |
Novonesis A/S has 3 bonds outstanding with $1.89B face value. The agencies rate it A-; its bonds trade like A. Weighted yield 4.13%, a spread of 93 bp over government bonds.